Home | Business News | CBJ Newsmakers | Pascal Biosciences Provides Corporate Update for First Quarter of 2019 Pascal Biosciences Provides Corporate Update for First Quarter of 2019 RecommendedAustralia Allows Prescription of MDMA and Psilocybin in Groundbreaking Regulatory ChangeParex Resources Announces 12 Consecutive Years of Reserves Per Share Growth, a 50% Increase to the Regular Dividend and Provides 2023 Guidance UpdateSandfire Resources America AnnouncesĀ Change of Auditor
